Remove our-approach-healthcare-commercial-intelligence
article thumbnail

Engaging HCPs in a changing landscape: 3 strategies for pharma

Definitive Healthcare

Resource Type Whitepapers & Research Whitepaper eBook Whitepaper Identify intelligent communication strategies in healthcare through social media Developing an omnichannel strategy for life sciences Driving impact and value: Tailored engagement strategies Image Image Image ","nextArrow":" ","appendArrows":".coh-slider-nav-bottom","dots":false,"draggable":true,"swipe":true,"fade":false,"vertical":false,"speed":700,"cssEase":"ease","pauseOnHover":false,"pauseOnDotsHover":false,"autop

article thumbnail

Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack

pharmaphorum

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment. And that’s why we are excited to welcome Chicago-based closerlook LLC to our pack. Meet closerlook.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Challenges and opportunities in the CGT supply chain

European Pharmaceutical Review

the success of CGT depends on a robust and reliable supply chain” Cell and gene therapies (CGT) offer a revolutionary approach to the treatment, prevention and potential cure of diseases. ” Artificial intelligence (AI) could also play a part in the future of the sector, however its application is not imminent.

article thumbnail

Achieving commercial excellence with data-driven decisions

pharmaphorum

Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that spans teams, functions, and geographies. How can we take an innovative approach to drive commercial success across the pharmaceutical industry? Who are your competitors?

article thumbnail

Verix boosts life science AI capabilities with start-up.ai acquisition

Pharmaceutical Technology

Artificial intelligence (AI)-driven commercial optimisation platform provider Verix has purchased start-up.ai Verix CEO Doron Aspitz stated: “In our time working with start-up.ai, we were consistently impressed with their AI capabilities and innovative approach to solving customer challenges. “As start-up.ai

52
article thumbnail

Newsletter – June 2023

Fuld & Company Blog

This month, we’re excited to share the latest trends in healthcare, private equity, technology, and transportation. We hope you will join our upcoming webinar , where our Health & Life Sciences guests will share their best practices and strategies for gathering and leveraging competitive intelligence to stay ahead in their sector.

article thumbnail

Viseven at Reuters Pharma EU

Viseven

This April was truly intense for Viseven in terms of events: weeks after visiting New York, our team went on to Reuters Pharma 2023 in Barcelona, while Korea Bio & Pharma meeting took place in Seoul the same weekend. Individual value is what drives commercial models of these companies and ensures their long-term success.